Revolutionizing Healthcare

Facebook recently announced a new product launching in limited beta – Graph Search. The product aims to completely restructure the current Facebook search functionality and create additional opportunities for users to discover new content and connections among their friends and within the entire Facebook platform.

Against a backdrop of shrinking budgets from NIH and elsewhere, FKH was proud to co-sponsor Funding the Next Discovery, a reception to benefit the American Cancer Society (ACS) on January 30, 2013.

Stay Healthy This Flu Season

In the United States, flu season can begin in October and can run as late as May, with peak activity typically seen in January or February. Flu awareness is critical, and FKH is proud of its ongoing work with Families Fighting Flu, a national nonprofit organization comprised mainly of families whose children have suffered serious medical complications or died from flu, to educate about the importance of flu prevention.

We have unmatched experience and personal sense of commitment to improve the lives of patients suffering from rare diseases.

The consumer genetics revolution is like travelling on the Japanese bullet train: the landscape seems familiar, but it’s going by so fast it’s hard to get your bearings. This year’s conference October 3-5, 2012, reflects changes in the industry, from the ‘gee whiz’ phase to products that deliver important information, with business models designed to go the distance. Feinstein Kean is the exclusive communications partner for this conference, based on our long history as the innovators’ friend in genomics and personalized medicine.

Patient advocacy is evolving from direct influence to direct impact. As patients become not just advocates but active drivers in product development, pharmaceutical and biotech companies will need to adapt their research models to take advantage of patient input, data, and investment. FKH CEO Craig Martin framed the conversation as chair of a panel discussion, [...]

On June 12, 2012, in Washington, D.C., the Personalized Medicine Coalition, the American Association for Cancer Research and Feinstein Kean Healthcare convened “Turning the Tide Against Cancer Through Sustained Medical Innovation,” a national conference to consider the status and future of cancer innovation and personalized medicine.

FKH has been working with Idis (see case study here) for the past 4 years to help educate audiences and raise awareness of the benefits of expanded access programs (EAPs). EAPs enable patients who have exhausted all other options to potentially gain access to drugs prior to their approval or launch, in full compliance with regulatory guidelines.